Monday, March 3rd, 2008
International Stem Cell Corporation (OTCBB:ISCO) announced that its human parthenogenetic stem cell lines will be used in Germany in studies aimed at creating specific cell types to treat human neural diseases such as Parkinson's disease.
The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany ...
Posted in Parkinson's Disease | No Comments »
Monday, March 3rd, 2008
Adult stem cells may provide an explanation for the cause of a Hutchinson-Gilford Progeria Syndrome (HGPS), a rare disease that causes premature aging in children, according to researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). These findings, the first to indicate a biological ...
Posted in Seniors / Aging | No Comments »
Thursday, February 28th, 2008
PrimeGen Biotech announced that company researchers have successfully used purified proteins and DNAs in non-viral methods to reprogram adult human cells into stem cells.
Participating in this week's Stem Cell Summit in New York, the company reported that this new class of stem cells -- derived from adult human tissues such ...
Posted in Stem Cell Research | No Comments »
Monday, February 25th, 2008
Advanced Cell Technology, Inc. (OTCBB: ACTC) reported for the first time a robust and highly efficient process for the generation of high-purity hepatocytes (liver cells). The research, described online (ahead of print) in the journal STEM CELLS, signifies a significant step towards the efficient generation of hepatocytes for use in ...
Posted in Stem Cell Research | No Comments »
Friday, February 22nd, 2008
Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) is pleased to announce favorable results from the investigator led BETAS (Beta-hCG + Erythropoietin in Acute Stroke), Phase IIa, open label, safety trial conducted at the University of California, Irvine and Hoag Presbyterian Memorial Hospital, Newport Beach, CA. This trial is the first ...
Posted in Stroke / Neuroprotection | No Comments »
Thursday, February 21st, 2008
Scientists at a US biotechnology company implanted immature beta-cells derived from human embryonic stem cells (hES cells) into mice and showed that they generated insulin-secreting cells that responded to raised blood sugar. They hope the discovery will one day lead to a renewable source of insulin-producing cells for the treatment ...
Posted in Diabetes | No Comments »
Wednesday, February 20th, 2008
Neural cells derived from human embryonic stem cells helped repair stroke-related damage in the brains of rats and led to improvements in their physical abilities, according to a new study by researchers at the Stanford University School of Medicine.
This study, to be published in the Feb. 20 issue of the ...
Posted in Stroke / Neuroprotection | No Comments »
Wednesday, February 20th, 2008
Tumors require a blood supply to grow, but how they acquire their network of blood vessels is poorly understood. A new study here shows that tumor blood vessels can develop from precancerous stem cells, a recently discovered type of cell that can either remain benign or become malignant.
Researchers say the ...
Posted in Cancer / Oncology | No Comments »
Monday, February 18th, 2008
In a retrospective review of blood disorder patients treated with stem cells from their own cord blood (autologous transplant) or from the cord blood of a sibling (allogeneic-related transplant), the majority of the patients were cured or achieved remission from their disease, according to a report presented today at the ...
Posted in Stem Cell Research | No Comments »
